Ilumya

tildrakizumab · Sun Pharmaceutical Industries

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Ilumya, covering 2015-03-30 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis [Phase 2, Phase 3]